HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James L Reading Selected Research

Immunotherapy

1/2020The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
10/2019Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
11/2018Urine-derived lymphocytes as a non-invasive measure of the bladder tumor immune microenvironment.
1/2018The function and dysfunction of memory CD8+ T cells in tumor immunity.
12/2016Too Much of a Good Thing? Chronic IFN Fuels Resistance to Cancer Immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James L Reading Research Topics

Disease

8Neoplasms (Cancer)
11/2022 - 12/2016
3Lung Neoplasms (Lung Cancer)
07/2020 - 01/2019
2Autoimmune Diseases (Autoimmune Disease)
01/2021 - 05/2013
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2021 - 01/2018
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
11/2015 - 05/2013
1Carcinoma (Carcinomatosis)
11/2022
1Renal Cell Carcinoma (Grawitz Tumor)
11/2021
1Hypoglycemia (Reactive Hypoglycemia)
01/2021
1Melanoma (Melanoma, Malignant)
01/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020
1Urinary Bladder Neoplasms (Bladder Cancer)
11/2018
1Lymphopenia (Lymphocytopenia)
01/2018
1HIV Infections (HIV Infection)
03/2012
1Infections
05/2011

Drug/Important Bio-Agent (IBA)

3CytokinesIBA
01/2021 - 05/2013
2Immune Checkpoint InhibitorsIBA
11/2022 - 12/2016
2RNA (Ribonucleic Acid)IBA
01/2021 - 01/2019
2cyclopropapyrroloindoleIBA
01/2021 - 01/2020
2AntigensIBA
01/2021 - 01/2021
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2020 - 10/2019
1NivolumabIBA
11/2021
1Biomarkers (Surrogate Marker)IBA
01/2020
1ProstaglandinsIBA
01/2018
1Interleukin-2 (IL2)IBA
11/2015
1Interleukin-10 (Interleukin 10)IBA
05/2013
1whey acidic proteinsIBA
03/2012
1VaccinesIBA
03/2012
1Anti-Infective Agents (Microbicides)IBA
03/2012
1Reverse Transcriptase InhibitorsIBA
05/2011

Therapy/Procedure

5Therapeutics
11/2022 - 11/2018
5Immunotherapy
01/2020 - 12/2016
2Transplantation
01/2021 - 01/2018
2Islets of Langerhans Transplantation
01/2021 - 05/2013
2Cell- and Tissue-Based Therapy (Cell Therapy)
01/2020 - 01/2018